9,119,842
|
Therapeutic meso-biliverdin IXα compositions and associated methods |
Sep 16, 13 |
Sep 01, 15 |
UTAH STATE UNIVERSITY RESEARCH FOUNDATION, UTAH STATE UNIVERSITY |
9,119,843
|
Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions |
Dec 03, 10 |
Sep 01, 15 |
CALIPER LIFE SCIENCES, INC., CALIPER LIFE SCIENCES INC. |
9,119,844
|
Use of quaternary pyridinium salts as vasoprotective agents |
Jun 12, 14 |
Sep 01, 15 |
PHARMENA SPOLKA AKCYJNA (PHARMENA S.A.), PHARMENA SPOLKA AKCYJNA (PHARMENA S.A.) |
9,119,845
|
Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
Nov 08, 10 |
Sep 01, 15 |
AMICUS THERAPEUTICS, INC., AMICUS THERAPEAUTICS, INC. |
9,119,846
|
Method and composition for enhancing cognition in alzheimer's patients |
Sep 10, 14 |
Sep 01, 15 |
NEURIM PHARMACEUTICALS (1991) LTD., NEURIM PHARMACEUTICALS (1991) LTD. |
9,119,847
|
Neferine and the use thereof in treating huntington disease |
Dec 08, 14 |
Sep 01, 15 |
MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY, MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY |
9,119,848
|
Morphinan derivatives for the treatment of drug overdose |
Oct 13, 10 |
Sep 01, 15 |
ALKERMES PHARMA IRELAND LIMITED, ALKERMES PHARMA IRELAND LIMITED |
9,119,849
|
Substituted guar protein extracts and production/applications thereof |
Aug 07, 06 |
Sep 01, 15 |
RHODIA CHIMIE, RHODIA CHIMIE |
9,119,850
|
Compositions and methods for weight loss in at risk patient populations |
Mar 02, 15 |
Sep 01, 15 |
OREXIGEN THERAPEUTICS, INC., OREXIGEN THERAPEUTICS, INC. |
9,119,851
|
Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals |
Jun 25, 14 |
Sep 01, 15 |
NEUREN PHARMACEUTICALS LIMITED, NEUREN PHARMACEUTICALS LTD. |
9,119,852
|
Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline |
Feb 17, 12 |
Sep 01, 15 |
NEUREN PHARMACEUTICALS LIMITED, Not available |
9,119,854
|
Methods for treating cancer using combination therapy |
May 02, 14 |
Sep 01, 15 |
CELGENE CORPORATION, CELGENE CORPORATION |
9,119,855
|
Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents |
Jan 23, 14 |
Sep 01, 15 |
ASYMMETRIC THERAPEUTICS, LLC, ASYMMETRIC THERAPEUTICS LLC |
9,119,856
|
Method for treating cancer using a dihydropyrimidine derivative |
Mar 23, 15 |
Sep 01, 15 |
KING SAUD UNIVERSITY, KING SAUD UNIVERSITY; KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER; |
9,119,857
|
Small molecule activators of HsIV protease for development of novel antimicrobials |
Jun 17, 13 |
Sep 01, 15 |
KING SAUD UNIVERSITY, Not available |
9,119,858
|
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity |
Aug 20, 13 |
Sep 01, 15 |
GENESYS RESEARCH INSTITUTE INC., GENESYS RESEARCH INSTITUTE, INC. |
9,119,859
|
Methods for treating otic infections |
Aug 15, 13 |
Sep 01, 15 |
ALCON RESEARCH, LTD., ALCON RESEARCH LTD. |
9,119,860
|
Agent for use in the case of fructose intolerance |
Mar 15, 13 |
Sep 01, 15 |
VITACARE GMBH & CO. KG, VITACARE GMBH & CO. KG |
9,119,861
|
Piroxicam-containing transdermally absorbable preparation |
Dec 14, 10 |
Sep 01, 15 |
TEIKOKU SEIYAKU CO., LTD., TEIKOKU SEIYAKU CO., LTD. |
9,119,862
|
Compositions, methods and kits for treating cancer |
Jul 18, 14 |
Sep 01, 15 |
THE PENN STATE RESEARCH FOUNDATION, THE PENN STATE RESEARCH FOUNDATION |